These ABSI calls are now up 185% in 2 weeks. One thing that gave me conviction on the initial trade was looking at insider transactions. Two wit, in regards to ABSI, two of the buyers — Frans Van Houten (former Philips CEO) and Menelas Pangalos (former Executive VP of BioPharmaceuticals R&D at AstraZeneca) — are heavyweight outside directors with deep industry expertise and no compensation incentive to "support the stock." Pangalos increased his stake by 527% and Van Houten by 172% in open-market trades. Lastly, the Chief Innovation Officer bought TWICE — and the second time, right before retiring. ABSI announced on March 3, 2026 that CIO Andreas Busch would retire March 31, 2026 and continue to co-chair Absci's Scientific Advisory Board. He nonetheless bought $229K of stock on March 12, 2026 — nine days into a publicly known retirement transition. Retiring executives typically liquidate, not accumulate. He'd already bought $152K back in July 2025. TLDR: Earnings are next week and insiders are buying into the ABS-201 interim readouts that now define the company's value. 🍌(CryptoCondom)